M&A Deal Summary

Allergan Acquires Andrx

On November 6, 2006, Allergan acquired life science company Andrx

Acquisition Highlights
  • This is Allergan’s 1st transaction in the Life Science sector.
  • This is Allergan’s 4th transaction in the United States.
  • This is Allergan’s 1st transaction in Florida.

M&A Deal Summary
Date 2006-11-06
Target Andrx
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition

Target

Andrx

Davie, Florida, United States
Andrx Corporation is engaged in the formulation and commercialization of oral controlled-release pharmaceuticals utilizing its proprietary drug delivery technologies. In its ANDA program, Andrx is developing bio-equivalent or generic versions of selected high sales volume controlled-release brand name pharmaceuticals.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 5 of 38
Sector (Life Science) 1 of 23
Type (Add-on Acquisition) 4 of 31
State (Florida) 1 of 2
Country (United States) 4 of 27
Year (2006) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-04-13 Watson Pharma Private

Mumbai, India

Watson Pharma Private Ltd is a manufacturer of chemicals and generic pharmaceutical products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-11-21 ZAO ZiO-Zdorovie

Podolsk, Russia

ZAO ZiO-Zdorovie is a pharmaceutical company.

Buy €47M
Mergr

Product

Company

Legal